• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Rezolute, Inc. - Common Stock (NV) (NQ:RZLT)

    4.605 -0.095 (-2.02%)
    Streaming Delayed Price Updated: 12:17 PM EDT, Aug 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 223,803
    Open 4.760
    Bid (Size) 4.600 (200)
    Ask (Size) 4.610 (700)
    Prev. Close 4.700
    Today's Range 4.545 - 4.840
    52wk Range 1.070 - 11.46
    Shares Outstanding 57,943,066
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Rezolute to Participate in the BTIG Virtual Biotechnology Conference
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
    From Rezolute, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +112.7%
    +112.7%
    1 Month
    -7.3%
    -7.3%
    3 Month
    +49.0%
    +49.0%
    6 Month
    +57.7%
    +57.7%
    1 Year
    -19.1%
    -19.1%

    More News

    Read More
    News headline image
    Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute to Participate in Upcoming Investor Conferences
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
    From Rezolute, Inc.
    Via GlobeNewswire
    Which stocks are gapping on Wednesday? ↗
    Via Chartmill
    News headline image
    Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Launches Investigation into Rezolute
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    Rezolute to Participate in the Citizens Life Sciences Conference
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    RZLT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    RZLT SECURITIES ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
    From Rezolute, Inc.
    Via GlobeNewswire
    News headline image
    SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism
    From Rezolute, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Rezolute, Inc. - Common Stock (NV) publicly traded?
    Yes, Rezolute, Inc. - Common Stock (NV) is publicly traded.
    What exchange does Rezolute, Inc. - Common Stock (NV) trade on?
    Rezolute, Inc. - Common Stock (NV) trades on the Nasdaq Stock Market
    What is the ticker symbol for Rezolute, Inc. - Common Stock (NV)?
    The ticker symbol for Rezolute, Inc. - Common Stock (NV) is RZLT on the Nasdaq Stock Market
    What is the current price of Rezolute, Inc. - Common Stock (NV)?
    The current price of Rezolute, Inc. - Common Stock (NV) is 4.605
    When was Rezolute, Inc. - Common Stock (NV) last traded?
    The last trade of Rezolute, Inc. - Common Stock (NV) was at 08/07/26 12:17 PM ET
    What is the market capitalization of Rezolute, Inc. - Common Stock (NV)?
    The market capitalization of Rezolute, Inc. - Common Stock (NV) is 266.83M
    How many shares of Rezolute, Inc. - Common Stock (NV) are outstanding?
    Rezolute, Inc. - Common Stock (NV) has 267M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.